News in the Life Sciences Industry

- Belantamab mafodotin accepted for accelerated assessment by the EMA's Committee for Human Medicinal Products (CHMP)

MARLBOROUGH, Mass. and BERLIN, Jan. 31, 2020 /PRNewswire/ -- Candela Corporation, a leading global medical aesthetic device company, has entered into an exclusive collaboration agreement with MT.DERM GmbH for the commercialization of MT.DERM's medical microneedling products. Under the terms... Read more ››

ABBOTT PARK, Ill., Jan. 30, 2020 /PRNewswire/ -- Abbott (NYSE: ABT) today announced that its Tendyne(TM) Transcatheter Mitral Valve Implantation (TMVI) system received CE Mark and is now approved for use in Europe. This life-changing therapy treats significant mitral regurgitation (MR) in patients... Read more ››

SUZHOU, JIANGSU, China, Jan. 28, 2020 /PRNewswire/ -- According to a researcher at Xi'an Jiaotong-Liverpool University, the Wuhan coronavirus, nCoV-2019, is closely related to SARS from the viewpoint of virus evolution.

ABBOTT PARK, Ill., Jan. 24, 2020 /PRNewswire/ -- Abbott (NYSE: ABT) today announced it received approval from the U.S. Food and Drug Administration (FDA) for a new, expanded indication for the company's Infinity(TM) Deep Brain Stimulation (DBS) system to include targeting of an area of the brain... Read more ››

BERLIN and MIAMI, Jan. 24, 2020 /PRNewswire/ -- ATAI Life Sciences AG ("ATAI" or the "Company"), a global... Read more ››

HAMBURG, Germany, Jan. 23, 2020 /PRNewswire/ -- Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809) and Indivumed GmbH ("Indivumed") today announced that the companies have entered into a new research collaboration to discover and develop first-in-class therapeutics for... Read more ››